Matching slides 96,741
Current window 88,231-88,260
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all

Component

88,231-88,260 of 96,741

filter-aware
09
The diagram represents a flywheel or iterative process loop.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
32
The slide highlights the scale of the antibody discovery pipeline and the distribution of therapeutic focus areas.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
39
The slide uses a mass spectrometry plot to show the shift in molecular mass after conjugation, highlighting the precision of the Absci platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a pipeline table format to show the progression of various drug candidates (SPY001-SPY230) across discovery, IND-enabling, and clinical stages.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Golden Circle1 hit
06
The slide uses a donut chart to compare 2021 and 2028 market sizes, highlighting growth.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Golden Circle1 hit
07
Aeglea BioTherapeutics | Investor Presentation Deck | 56 slidesAeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Golden Circle1 hit
24
The chart compares benchmark induction remission rates with vedolizumab exposure quartiles.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
34
Includes visual representation of antibody binding mechanisms.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Evidence1 hit
40
The chart uses a waterfall-style logic to show the additive effect of the combination therapy.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Evidence1 hit
45
The slide uses a comparative framework to validate the efficacy of CDx-guided patient selection.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
48
The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
49
The chart uses a custom range bar (min/max) with markers for IPO and Today's market cap.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
50
The slide uses a timeline-based comparison to suggest that Spyre's assets are on a similar trajectory to high-value acquired assets.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
53
Aeglea BioTherapeutics | Investor Presentation Deck | 56 slidesAeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
56
Includes two distinct chart types: a scatter plot for half-life correlation and bar charts for ADA rates.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
06
The slide uses a split-screen layout to contrast established proof-of-concept (left) with future development plans (right).argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
08
Includes a callout for cash position at end of Q2 2023.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · KPIsLoop · Pareto Focus1 hit
13
The slide uses a patient story to humanize the clinical goals of minimizing burden and achieving sustained responses.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
20
Uses a primary source document (Senate letter) and a court observation to build a narrative of corporate malfeasance.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor Beat · The Struggle1 hit
22
Uses a green checkmark icon to signify compliance and a yellow callout box to emphasize the rebuttal.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor 1 hit
25
Uses a visual metaphor (Pinocchio) to attack the credibility of the target company's management.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor 1 hit
28
Uses a famous quote about insanity to frame the CEO's long tenure as a failure.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor Beat · The Call1 hit
29
Uses a press release excerpt to expose a contradiction between the director's stated qualifications and the company's current strategic needs.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor Beat · The Call1 hit
30
Uses a callout box to frame the nominee's history as a negative.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor Beat · The Call1 hit
32
Includes a call to action for the upcoming General Meeting.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor Beat · The Victory1 hit
33
Sarissa Capital | Activist Presentation Deck | 36 slidesSarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor 1 hit
13
The slide outlines the legal and financial framework of the loss protection agreement, including specific thresholds and reporting timelines.UBS | Mergers and Acquisitions Presentation Deck | 17 slides · UBS
Regulatory filing Investment bank Beat · SolutionLoop · Voice Of Customer1 hit
11
The slide uses a hub-and-spoke style organizational structure to illustrate business units.Unilever | Investor Conference Presentation Deck | 32 slides · Unilever
Conference presentation Investor relations Beat · Evidence & Proof1 hit
11
The chart shows a clear transition from ICE to EV production over time, culminating in a 2023 target of zero ICE production.VinFast | Investor Presentation Deck | 42 slides · VinFast
Pitch deck Investor relations Loop · Golden Circle1 hit
05
Vivid Seats | Investor Presentation Deck | 24 slidesVivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Beat · Traction1 hit